共查询到18条相似文献,搜索用时 15 毫秒
1.
Yasmin Sultana Neisha Jeoffreys Matthew R. Watts Gwendolyn L. Gilbert Rogan Lee 《The American journal of tropical medicine and hygiene》2013,88(6):1048-1051
The use of real-time polymerase chain reaction (PCR) for detection of Strongyloides stercoralis in stool has recently been described. We compared five DNA extraction methods by using normal human stool spiked with Strongyloides ratti and tested by using a real-time PCR. The PowerSoil kit was found to be the best technique in terms of sensitivity and ease of use. The PCR detected DNA extracted from one spiked S. ratti larva diluted 10−2. The PowerSoil kit was then used to extract DNA from 160 human survey samples. All culture positive specimens with a high and moderate larval load were identified by real-time PCR, but only 15% of specimens with low larval load were positive. Specificity was greater than 99%. The combination of the PowerSoil kit and real-time PCR reliably detected high to moderate larval numbers of S. stercoralis in stools but was less sensitive when the larval load was low. 相似文献
2.
Atchara Phumee Kanyarat Kraivichian Sarunyou Chusri Nopadon Noppakun Asda Vibhagool Vivornpun Sanprasert Vich Tampanya Henry Wilde Padet Siriyasatien 《The American journal of tropical medicine and hygiene》2013,89(5):899-905
Polymerase chain reaction was used to detect Leishmania siamensis DNA from clinical samples collected from six leishmaniasis patients during 2011–2012. The samples used in this study came from bone marrow, blood, buffy coat, saliva, urine, and tissue biopsy specimens. Saliva was a good source for L. siamensis DNA by polymerase chain reaction. L. siamensis DNA was also found in saliva of an asymptomatic case-patient. Levels of L. siamensis DNA in saliva decreased until being undetectable after treatment. These levels could be used as a marker to evaluate efficacy of the treatment. A larger study is needed to evaluate this method as a screening and survey tool to study the silent background of Leishmania infection among the at-risk population.Leishmaniasis is a neglected tropical diseases caused by an obligate intracellular protozoa belonging to the genus Leishmania. The disease is transmitted to vertebrate hosts by infected female sand flies taking a blood meal.1 Leishmaniasis presents in three clinical forms; visceral, cutaneous, and mucocutaneous.2 Clinical presentation of leishmaniasis depends on the species of Leishmania and the immunity of the host.3Detection and species identification of the parasites is essential for prognostic and therapeutic reasons and surveys.4 Several laboratory techniques have been used for diagnosis of Leishmania infection. They are microscopy, culture, immunologic techniques (enzyme-linked immunosorbent assay, direct agglutination test, and recombinant protein K39 dipstick test), and molecular techniques (polymerase chain reaction [PCR] and quantitative PCR).5–7 In comparisons of microscopic examination, culture, and PCR in detecting Leishmania parasites, PCR has shown to have a significantly higher sensitivity than culture and microscopic examination (97%, 78%, and 76%8–10 sensitivity, respectively). New cases of leishmaniasis caused by L. siamensis, a novel species of Leishmania, have been documented in patients in Thailand11–17 and Myanmar (unpublished data). The infection was described in immunocompromised patients, mostly persons infected with human immunodeficiency virus (HIV).11–17 Clinical presentations of these patients have included visceral,11–13 diffuse cutaneous,15 and overlapping diffuse cutaneous and visceral forms.14With low prevalence of leishmaniasis in Thailand and Myanmar, screening tests for leishmaniasis such as enzyme-linked immunosorbent assay, direct agglutination test, and recombinant protein K39 dipstick test are not readily available. Moreover, sensitivity and specificity of these serologic tests for detection of L. siamensis infection have never been fully documented. Diagnosis of L. siamensis infection relies on microscopic examination, culture, and detection of parasite DNA by PCR.11–15 Although microscopic examination and culture of Leishmania parasites have high specificity, they require experience and have low sensitivity. The PCR is commonly used to diagnose leishmaniasis caused by L. siamensis. Bone marrow, blood, buffy coat, tissue, saliva, and urine have been successfully used for detection of L. siamensis DNA by PCR.14Saliva has shown to be a good source for L. siamensis DNA.14 There are also reports of using saliva to identify other Leishmania species.18–20 Collection of saliva is noninvasive and convenient for field studies. We describe a PCR to amplify the internal transcribed spacer1 (ITS1) gene of L. siamensis from six infected patients and compare it with specimens collected from patients and different clinical presentations. Details of clinical presentations and management of some patients enrolled in this study have been described.14Bone marrow, blood or saliva was smeared on glass slides, and fixed with absolute methanol (Sigma-Aldrich, St. Louis, MO) for one minute. The slides were then stained with Giemsa (Sigma-Aldrich) in phosphate buffer, pH 7.2. Tissue biopsy specimens were stained with hematoxylin and eosin. Stained slides were then examined under a light microscope (Olympus, Tokyo, Japan).Schneider''s insect medium (Sigma-Aldrich) containing 20% fetal bovine serum, 100 U/mL of penicillin, and 100 mg/mL of streptomycin (Sigma-Aldrich) was used for culturing Leishmania parasites. One hundred microliters of bone marrow, blood, or saliva was inoculated into 5 mL of culture media in a 25-cm3 flask and incubated at 25 ± 2°C. Cultures were inspected for parasites every 24 hours by using an inverted microscope (Olympus).Two hundred microliters of blood or bone marrow and 50 μL of buffy coat were used for DNA extraction by using a blood DNA extraction kit (Invisorb® Spin Blood Mini Kit (STRATEC Molecular, Berlin, Germany). Thirty milliliters of urine or 1 mL of saliva were centrifuged for 5 minutes at 5,000 × g, and the pellets were collected and used for further DNA extraction. Tissue specimens, urine pellets, and saliva pellets were used for DNA extraction by tissue DNA extraction (Invisorb® Spin Tissue Mini Kit) according to the manufacturer''s instructions. Extracted DNA was eluted in 80 μL of elution buffer. Quantity and quality of the extracted DNA was determined by using a Nanodrop 2000c Apparatus (Thermo Scientific, Singapore). Extracted DNA samples were kept at −80°C for long-term storage. Blood, saliva, and urine were collected from three healthy uninfected persons and used for the PCR as negative controls.The PCR was performed in a final volume of 25 μL containing approximately 100 ng of extracted DNA, 10 μM of each primer, 25 mM of MgCl2, 2 mM of dNTPs, and 1 unit of Taq DNA polymerase (Fermentas, Pittsburgh, PA). The primers were designed to anneal specifically to the ITS1 regions of ribosomal RNA (rRNA) of Leishmania parasites described by Spanakos and others:21 (LeF: 5′-TCC GCC CGA AAG TTC ACC GAT A-3′ and LeR: 5′-CCA AGT CAT CCA TCG CGA CAC G-3′). The PCRs were performed in a PCR Mastercycler® Pro (Eppendorf, Hamburg, Germany) with conditions as follows: denaturation at 94°C for 4 minutes; followed by 40 cycles at 94°C for 1 minute, 65°C for 1 minute, and 72°C for 1 minute; and a final extension at 72°C for 7 minutes. Aliquots of the PCR amplicons were analyzed by electrophoresis on 1.5% agarose gels, stained with ethidium bromide, and visualized with Quantity One Quantification Analysis Software version 4.5.2 (Gel Doc EQ System; Bio-Rad, Hercules, CA). The extracted DNA samples from an uninfected persons and a no DNA template (double-distilled water) were used as negative controls in every PCR. Reactions in which either or both negative controls contained bands were discarded.Confirmatory testing for PCR was performed by using another set of primers to amplify the partial small subunit (SSU) rRNA genes of the Leishmania parasite. The primer sequences (R221: 5′-GGT TCC TTT CCT GAT TTA CG-3′ and R332: 5′-GGC CGG TAA AGG CCG AAT AG-3′) and PCR conditions were described by Van Eys and others.22The PCR amplicons were ligated into the pGEM-T Easy Vector (Promega, Madison, WI). Ligation reactions mixture was composed of 5 μL of 2× Rapid ligation buffer, 3 μL of PCR products, 1 μL pGEM-T Easy Vector, and 1 μL double-distilled water. The ligated vectors were transformed into DH5α competent cells and chimeric plasmids were screened by blue–white colony selection system. The suspected positive colonies were cultured and used for further plasmid DNA extraction by using the Invisorb® Spin Plasmid Mini Kit following the manufacturer''s instructions. Purified plasmids were sequenced by 1st BASE DNA sequencing services (1st Base Laboratories, Kuala Lumpur, Malaysia) by using universal forward T7 primer. Nucleotide sequences were analyzed by using BioEdit Sequence Alignment Editor Version 7.0.9.0 (www.mbio.ncsu.edu/bioedit/bioedit.html), and consensus sequences were compared with available sequence data in a GenBank by BLAST search (www.ncbi.nlm.gov/BLAST).The study was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (IRB no. 385/55).Patient 1 was a 46-year-old Thai man who was a rubber planter from southern Thailand. He has been given a diagnosis with HIV infection in 2003 and received boosted lopinavir and lamivudine. His CD4+ T cell count was 175 cells/mm3, and serum virus levels were < 40 copies/mL. He also had Evans syndrome (an autoimmune disorder with destruction of erythrocytes, platelets, and leukocytes), a left knee ulcer, and hepatosplenomegaly. A bone marrow study showed Leishmania amastigotes within macrophages. Bone marrow, blood, discharge from the ulcer, saliva, and urine were cultured and DNA was extracted for PCR.He improved after two weeks of intravenous amphotericin B deoxycholate (1 mg/kg/day), followed by 400 mg of itraconazole/day. A recurrence after two months of itraconazole therapy was re-treated with three weeks of intravenous liposomal amphotericin B (3 mg/kg/day), followed by 400 mg of itraconazole per day. Blood and saliva were collected for PCR three months after re-treatment and were negative. Details of this patient were reported by Chusri and others.14Patient 2 was 30-year-old pet store owner from southern Thailand who had been given a diagnosis of HIV infection in 1999. The patient received tenofovir, lamivudine, and nevirapine. His CD4+ T-cell count was 111 cells/mm3 and viral RNA was not detectable (< 40 copies/mL). He had multiple papules and plaques with ulceration and discharges. He also had anemia, thrombocytopenia, and hepatosplenomegaly. Bone marrow, papule, and ulcer biopsy specimens showed Leishmania amastigotes within macrophages. Bone marrow, blood, tissue biopsy specimens, and saliva and urine samples were used for culture and PCR. The patient received intravenous amphotericin B deoxycholate (1 mg/kg/day) for two weeks, followed by 400 mg of itraconazole per day. Blood and saliva were collected three months later and were negative for Leishmania and no recurrence was observed. This patient was reported by Chusri and others.14Patient 3 was a 60-year-old man with diabetes who lived in Yangon, Myanmar and had not previously traveled abroad. He showed development of fever, multiple infiltrative skin lesions, and oral ulcers. A skin biopsy specimen indicated Sweet''s syndrome or acute febrile neutrophilic dermatosis, which is a skin disease with fever and painful skin lesions that is commonly present on arms, neck, face, and back. He was treated with systemic corticosteroids for two months without improvement. He came to Thailand for further evaluation. Multiple erythematous, shiny, infiltrative plaques; nodules on face, trunk, and extremities; and oral ulcers and white patches on the buccal mucosa were observed. Lymph nodes, liver, and spleen were not palpable. Complete blood counts, blood urea nitrogen levels, creatinine levels, and liver function test results were within normal limits. Results for antinuclear antibodies, antibodies against HIV, and C-reactive protein levels were unremarkable.A new skin biopsy specimen of a trunk nodule showed diffuse histiocytic infiltrate and multinucleated giant cells in the upper and deep dermis. Many round-to-oval small organisms were present in histiocytes and fibrous stroma. They stained positive with Periodic Acid–Schiff (PAS) stain. Numerous small yeast-liked organisms were present in histiocytes and in the stroma. Some of these organisms were large and contained small basophilic dots in cytoplasm near nuclei stained positively with PAS stain but not with Gomori''s methenamine silver stain and Giemsa. This finding suggested the presence of Leishmania parasites. Blood samples, tissue biopsy specimens, saliva and urine samples were used for culture and were negative. PCR testing of the ITS1 region of the rRNA gene in blood, skin biopsy specimen, urine, and saliva, and DNA sequencing identified L. siamensis. The patient was treated with intravenous amphotericin B for 40 days (total dose = 2.1 grams). After regression of the cutaneous lesions, he was discharged. When seen again two months later, he had gained weight but a few skin lesions were still present. He returned home and was lost to follow-up.Patient 4 was the 22-year-old daughter of patient 3; she came to Thailand with her father. She was healthy and lived with her father in Yangon. Results of her physical examination were unremarkable. Saliva and urine samples were collected and used for culture; these samples were negative for L. siamensis. PCR testing of the ITS1 region of the rRNA gene in saliva DNA, followed by DNA sequencing, identified L. siamensis. Whole blood and buffy coat were then collected for Leishmania detection by culture, staining with Giemsa, and PCR. Only PCR identified L. siamensis in buffy coat. We planned to follow-up the patient for detection of Leishmania parasites without treatment of leishmaniasis but the patient was lost to follow-up.Patient 5 was a 45-year-old Thai man living in Chiang Rai, Thailand. He has been given a diagnosis of HIV infection in 2005. He had a CD4+ T cell count of < 50 cells/mm3. He was treated with stavudine, lamivudine, and nevirapine. In 2007, He showed development of lumpy skin lesions that were first not investigated. He was later hospitalized with fever, oral candidiasis, pancytopenia, pancreatitis, type 2 diabetes mellitus, epistaxis, perianal abscess, urinary retention, and abnormal liver function test results. Skin biopsy specimens from lesions present for more than five years showed epidermal hyperplasia, diffuse fibrosis, dilated blood vessels, and mild perivascular lymphohistiocytic infiltrates in the dermis. There were a few clumps of small parasites in histiocytes and extracellularly between collagen fibers in the upper dermis. They stained with Giemsa. Blood, tissue biopsy specimen, and saliva and urine samples were used for culture but were negative. A PCR of ITS1 region of the rRNA gene in blood, tissue biopsy specimen, and saliva DNA, followed by DNA sequencing, confirmed the presence of L. siamensis. The patient was then confirmed as having cutaneous leishmaniasis. He was severely debilitated and died of systemic bacterial infection without treatment of leishmaniasis.Patient 6 was a 34-year-old Burmese man from Yangon who was seropositive for HIV for six years. He was treated with truvada, legalon, isoniazid, rifampicin, ethambutal, and pyrazinamide. Five months later, he was hospitalized with high fever and diarrhea. He was empirically treated with clarithromycin and moxifloxacin. He showed development of multiple, umbilicated, erythematous papules on his neck, arms, and chest wall. Skin biopsy specimens showed a moderately dense superficial and deep perivascular and interstitial histiocytic infiltrate. Many small yeast-like organisms were present in the cytoplasm of histiocytes and between collagen fibers. They stained with PAS and Giemsa, leading to diagnosis of cutaneous leishmaniasis. Blood, tissue, saliva, and urine samples were cultured. A PCR of the ITS1 region of the rRNA gene in blood, skin biopsy specimen, and saliva DNA, followed by DNA sequencing, identified L. siamensis. The patient was treated with liposomal amphotericin B and anti-tuberculosis therapy was continued. Clinical recovery resulted within one month.Specimens were obtained from patients with different clinical presentations of leishmaniasis (Patient Age (years) Sex/nationality Clinical presentation/host conditions Microscopic examination/culture for Leishmania PCR detection of L. siamensis DNA Reference Blood smear Skin biopsy Blood/bone marrow culture Bone marrow Blood Buffy coat Saliva Urine Tissue 1 46 M/Thai CL and VL/HIV infection and prednisolone therapy + N/A +/+ + + + + + N/A Chusri and others14 2 30 M/Thai CL and VL/HIV infection + + –/+ + + + + + + Chusri and others14 3 60 M/Burmese CL/DM and Prednisolone therapy – + –/N/A N/A + + + + + Unpublished data 4 22 F/Burmese Asymptomatic/normal – N/A –/N/A N/A - + + – N/A Unpublished data 5 45 M/Thai CL/HIV infection – + –/N/A N/A + + + – + Unpublished data 6 34 M/Burmese CL/HIV infection – + –/N/A N/A + + + – + Unpublished data